Prosight Management, LP
Top Portfolio Positions
45 positions ·
$577,641,288 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| NKTR |
Nektar Therapeutics
Healthcare
|
735,000 | $52,883,250 | 9.16% | |
| BSX |
Boston Scientific Corp
Healthcare
|
795,547 | $49,920,574 | 8.64% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
3,550,000 | $49,345,000 | 8.54% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
1,945,000 | $48,644,450 | 8.42% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
1,550,000 | $46,500,000 | 8.05% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
523,463 | $33,616,793 | 5.82% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
8,300,000 | $31,125,000 | 5.39% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
3,356,700 | $27,289,971 | 4.72% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
76,000 | $25,146,120 | 4.35% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
2,629,971 | $22,775,548 | 3.94% |
Portfolio Trend
Holdings in ZYME
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,497,786 | 539,049 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,965,247 | 530,393 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,803,355 | 749,611 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,439,295 | 1,309,904 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,400,597 | 957,229 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,004,800 | 820,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,515,867 | 917,599 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,041,800 | 1,180,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,323,172 | 410,948 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $674,607 | 106,405 | Shares | Sole | 2023-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||